Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:18:25 EDT Tue 30 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:CRL from 2023-05-01 to 2024-04-30 - 52 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-22 08:00U:CRLNews ReleaseCharles River Laboratories Achieves 100% Renewable Electricity Usage Globally
2024-04-16 08:00U:CRLNews ReleaseCharles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
2024-04-12 08:00U:CRLNews ReleaseCharles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
2024-04-11 08:00U:CRLNews ReleaseCharles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
2024-04-09 08:00U:CRLNews ReleaseCharles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
2024-04-04 08:00U:CRLNews ReleaseCharles River to Perform Plasmid Production for Ship of Theseus
2024-04-04 08:00U:CRLNews ReleaseCharles River to Perform Plasmid Production for Ship of Theseus
2024-04-01 08:00U:CRLNews ReleaseCharles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
2024-03-27 08:00U:CRLNews ReleaseCharles River Laboratories Publishes 2023 Corporate Citizenship Report
2024-03-21 08:00U:CRLNews ReleaseCharles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
2024-03-14 08:00U:CRLNews ReleaseCharles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
2024-03-12 08:00U:CRLNews ReleaseCharles River Laboratories to Present at Barclays Global Healthcare Conference
2024-02-29 02:00U:CRLNews ReleaseWheeler Bio Seals Agreement with Charles River to Offer Portable CMC(TM) to Discovery Clients to Accelerate Their Journey to First-in-Human Use
2024-02-21 08:00U:CRLNews ReleaseCharles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
2024-02-20 08:08U:CRLNews ReleaseCharles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells
2024-02-14 07:00U:CRLNews ReleaseCharles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
2024-01-29 08:00U:CRLNews ReleaseCharles River Introduces the First Rapid Animal-Free Bacterial Endotoxin Test
2024-01-24 16:30U:CRLNews ReleaseCharles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors
2024-01-23 16:30U:CRLNews ReleaseCharles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call
2024-01-16 08:00U:CRLNews ReleaseCharles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector Manufacturing
2024-01-08 08:00U:CRLNews ReleaseCharles River Laboratories to Present at J.P. Morgan Healthcare Conference
2023-12-18 08:00U:CRLNews ReleaseCharles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing Collaboration
2023-12-12 08:00U:CRLNews ReleaseCharles River Finalizes Agreement with CELLphenomics, Expanding 3D In Vitro Services for Cancer Therapy Drug Screening
2023-11-28 08:00U:CRLNews ReleaseCharles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration
2023-11-27 08:30U:CRLNews ReleaseCharles River Laboratories to Present at Evercore ISI Investor Conference
2023-11-16 08:00U:CRLNews ReleaseCharles River Introduces CliniPrime Cryopreserved Leukopaks, Expanding Suite of GMP-Compliant Cellular Products
2023-11-13 09:04U:CRLNews ReleaseCharles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
2023-11-13 09:00U:CRLNews ReleaseCharles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
2023-11-09 08:00U:CRLNews ReleaseCharles River Laboratories ¢ € ™ Industry Experts to Present Advanced Modalities at Neuroscience 2023
2023-11-08 07:00U:CRLNews ReleaseCharles River Laboratories Announces Third-Quarter 2023 Results
2023-10-19 08:00U:CRLNews ReleaseCharles River Launches Real-Time Research Model Ordering, Introducing an Important Digital Innovation to Research Models & Services Business
2023-10-16 08:30U:CRLNews ReleaseCharles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call
2023-10-16 08:00U:CRLNews ReleaseCharles River Laboratories Provides Access to Relevant, Well-Characterized Pediatric PDX Collection for Oncology Research
2023-10-11 08:00U:CRLNews ReleaseCharles River Laboratories Achieves 90% Renewable Electricity Globally, Announces Progress on Environmental Goals
2023-09-26 08:00U:CRLNews ReleaseCharles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing
2023-09-25 08:00U:CRLNews ReleaseCharles River Announces Opening of RightSourceSM Laboratory, Supporting Stevenage Biocluster
2023-09-20 08:30U:CRLNews ReleaseCharles River Laboratories to Host Virtual Investor Day
2023-09-14 08:00U:CRLNews ReleaseCharles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica
2023-09-11 08:00U:CRLNews ReleaseCharles River Laboratories to Present at Baird and Morgan Stanley Conferences
2023-09-06 08:00U:CRLNews ReleaseCharles River and PathoQuest Announce Publication of a Head-to-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay as a Reliable In Vitro Alternative to Animal Testing Methods
2023-08-24 08:00U:CRLNews ReleaseCharles River Laboratories Announces Plasmid Manufacturing Collaboration with Fondazione Telethon
2023-08-09 07:00U:CRLNews ReleaseCharles River Laboratories Announces Second-Quarter 2023 Results
2023-08-01 08:00U:CRLNews ReleaseCharles River Laboratories Expands Access to AAALAC-Accredited, Turnkey Research Space in Key Markets
2023-07-19 08:00U:CRLNews ReleaseCharles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call
2023-06-13 04:30U:CRLNews ReleaseCharles River Laboratories Launches Off-the-Shelf Lentiviral Vector Packaging Plasmids
2023-06-12 08:00U:CRLNews ReleaseCharles River and Curigin Collaborate to Produce Oncolytic RNAi Gene Therapy
2023-06-08 16:30U:CRLNews ReleaseCharles River and INADcure Announce Gene Therapy Manufacturing Collaboration
2023-06-05 08:00U:CRLNews ReleaseCharles River Laboratories to Present at William Blair and Jefferies Conferences
2023-05-31 11:35U:CRLNews ReleaseWheeler Bio and Charles River Laboratories Announce Agreement to Build and Operate RightSource(SM) Laboratory
2023-05-31 08:00U:CRLNews ReleaseCharles River Laboratories and Wheeler Bio Announce Agreement to Build and Operate RightSourceSM Laboratory
2023-05-11 07:00U:CRLNews ReleaseCharles River Laboratories Announces First-Quarter 2023 Results
2023-05-01 08:00U:CRLNews ReleaseCharles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID